Genus plc (FRA:GBE)

Market Cap	1.88B +20.5%
Revenue (ttm)	770.31M +0.1%
Net Income	54.45M
EPS	0.81
Shares Out	n/a
PE Ratio	34.45
Forward PE	23.95
Dividend	0.38 (1.29%)
Ex-Dividend Date	Mar 5, 2026

Volume	n/a
Average Volume	23
Open	29.00
Previous Close	29.00
Day's Range	29.00 - 29.00
52-Week Range	18.10 - 36.40
Beta	n/a
RSI	36.41
Earnings Date	Sep 10, 2026

About Genus

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1994
• Employees: 3,190
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GBE

Financial Performance

In fiscal year 2025, Genus's revenue was 672.80 million, an increase of 0.60% compared to the previous year's 668.80 million. Earnings were 19.30 million, an increase of 144.30%.

Financial numbers in GBP